JP2019515643A5 - - Google Patents

Download PDF

Info

Publication number
JP2019515643A5
JP2019515643A5 JP2018515676A JP2018515676A JP2019515643A5 JP 2019515643 A5 JP2019515643 A5 JP 2019515643A5 JP 2018515676 A JP2018515676 A JP 2018515676A JP 2018515676 A JP2018515676 A JP 2018515676A JP 2019515643 A5 JP2019515643 A5 JP 2019515643A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
cycloalkyl
substituted
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018515676A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019515643A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/053571 external-priority patent/WO2017053886A2/en
Publication of JP2019515643A publication Critical patent/JP2019515643A/ja
Publication of JP2019515643A5 publication Critical patent/JP2019515643A5/ja
Priority to JP2021042947A priority Critical patent/JP7138207B2/ja
Pending legal-status Critical Current

Links

JP2018515676A 2015-09-23 2016-09-23 幹細胞分化剤のスクリーニング方法 Pending JP2019515643A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021042947A JP7138207B2 (ja) 2015-09-23 2021-01-08 幹細胞分化剤のスクリーニング方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562222713P 2015-09-23 2015-09-23
US62/222,713 2015-09-23
PCT/US2016/053571 WO2017053886A2 (en) 2015-09-23 2016-09-23 Method of screening for agents for differentiating stem cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021042947A Division JP7138207B2 (ja) 2015-09-23 2021-01-08 幹細胞分化剤のスクリーニング方法

Publications (2)

Publication Number Publication Date
JP2019515643A JP2019515643A (ja) 2019-06-13
JP2019515643A5 true JP2019515643A5 (https=) 2019-11-07

Family

ID=58387520

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018515676A Pending JP2019515643A (ja) 2015-09-23 2016-09-23 幹細胞分化剤のスクリーニング方法
JP2021042947A Active JP7138207B2 (ja) 2015-09-23 2021-01-08 幹細胞分化剤のスクリーニング方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021042947A Active JP7138207B2 (ja) 2015-09-23 2021-01-08 幹細胞分化剤のスクリーニング方法

Country Status (8)

Country Link
US (2) US11931347B2 (https=)
EP (1) EP3352566A4 (https=)
JP (2) JP2019515643A (https=)
CN (2) CN108513537A (https=)
AU (2) AU2016326718B2 (https=)
CA (1) CA2999503A1 (https=)
IL (3) IL258314B (https=)
WO (1) WO2017053886A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11931347B2 (en) 2015-09-23 2024-03-19 Minerva Biotechnologies Corporation Method of screening for agents for differentiating stem cells
EP3519816A4 (en) 2016-09-29 2020-05-06 The Regents of the University of California CONNECTIONS FOR INCREASING NEURONAL PLASTICITY
EP3600451B1 (en) * 2017-03-29 2025-12-24 Minerva Biotechnologies Corporation Agents for differentiating stem cells and treating cancer
CN107892690A (zh) * 2017-11-30 2018-04-10 江苏杏睿生物科技有限公司 Fascaplysin的衍生物及制备方法与用途
WO2019126357A1 (en) * 2017-12-19 2019-06-27 Minerva Biotechnologies Corporation Agents for treating cancer and methods for identifying said agents
CN107880040A (zh) * 2017-12-22 2018-04-06 中国药科大学 一种四氢β-咔啉类衍生物及其制备方法与用途
KR102946120B1 (ko) 2019-02-27 2026-03-30 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클
CA3183682A1 (en) 2020-06-26 2021-12-30 Minerva Biotechnologies Corporation Anti-nme antibody and method of treating cancer or cancer metastasis
US12104170B2 (en) 2020-06-26 2024-10-01 Minerva Biotechnologies Corporation Methods for deriving dopaminergic neurons from pluripotent stem cells
IL313455A (en) 2021-12-15 2024-08-01 Delix Therapeutics Inc Phenoxy and benzyloxy modified psychroplastogens and their uses
CN119317447A (zh) 2022-04-12 2025-01-14 米纳瓦生物技术公司 抗可变muc1*抗体及其用途
CN115521306B (zh) * 2022-09-26 2024-03-26 贵州大学 一种1,2,3,4-四氢-β-咔啉衍生物及其制备方法和应用
CN115594675B (zh) * 2022-11-02 2024-01-30 西安医学院 一种 β-卡巴林-肉桂酸骨架衍生物及制备方法和用途

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US7625697B2 (en) 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US20030099611A1 (en) * 1995-09-01 2003-05-29 Sara Lavi Manipulation and detection of protein phosphatase 2c-pp2calpha - expression in tumor cells for cancer therapy, prevention and detection
BR9709230A (pt) 1996-05-10 1999-08-10 Icos Corp Composto
AU2004216541A1 (en) * 2003-02-28 2004-09-10 Howard Florey Institute Of Experimental Physiology And Medicine Therapeutic compositions
CN1852974A (zh) * 2003-06-09 2006-10-25 密歇根大学董事会 用于治疗和诊断癌症的组合物和方法
US7872133B2 (en) * 2003-06-23 2011-01-18 Ono Pharmaceutical Co., Ltd. Tricyclic heterocycle compound
CN1910183A (zh) * 2004-01-23 2007-02-07 希龙公司 四氢咔啉化合物作为抗癌药
UA92317C2 (ru) * 2004-03-15 2010-10-25 Пи-Ти-Си ТЕРАПЬЮТИКС, ИНК. Производные карболина, пригодные для ингибирования развития кровеносных сосудов
US7767689B2 (en) * 2004-03-15 2010-08-03 Ptc Therapeutics, Inc. Carboline derivatives useful in the treatment of cancer
CA2584412C (en) * 2004-09-14 2017-05-09 Minerva Biotechnologies Corporation Methods for diagnosis and treatment of cancer
ES2720288T3 (es) 2005-03-30 2019-07-19 Minerva Biotechnologies Corp Proliferación de células que expresan MUC1
WO2007076055A2 (en) * 2005-12-22 2007-07-05 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
BRPI0718677A2 (pt) * 2006-11-03 2013-11-26 Irm Llc Compostos e composições como inibidores de quinases proteicas
US20090075926A1 (en) * 2006-12-06 2009-03-19 Bamdad Cynthia C Method for identifying and manipulating cells
WO2009022104A1 (en) 2007-08-13 2009-02-19 De Montfort University Fascaplysin derivatives and their use in the treatment of cancer
EP2214485B1 (en) 2007-09-25 2016-07-20 Minerva Biotechnologies Corp. Methods for treatment of cancer
EP2274617A4 (en) * 2008-04-10 2011-11-09 Massachusetts Inst Technology METHOD OF DETECTING AND USING MEDIUM-TREATMENT AID ON CANCER STEM CELLS
WO2009140260A2 (en) 2008-05-13 2009-11-19 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Cancer stem cell immortalization
EP3228629A1 (en) * 2010-06-16 2017-10-11 Minerva Biotechnologies Corporation Reprogramming cancer cells
JP2012068225A (ja) 2010-08-25 2012-04-05 Fujifilm Corp 放射線画像撮影用グリッド及びその製造方法
EP2561888A1 (en) 2011-08-23 2013-02-27 Deutsches Krebsforschungszentrum Protein comprising NC-1 for treating angiogenesis-related diseases
CN109456932A (zh) * 2011-10-17 2019-03-12 米纳瓦生物技术公司 用于干细胞增殖和诱导的培养基
WO2014036654A1 (en) 2012-09-06 2014-03-13 Mcmaster University Compounds and methods for selectively targeting cancer stem cells
CA2901893C (en) * 2013-02-20 2022-08-30 Minerva Biotechnologies Corporation Nme inhibitors and methods of using nme inhibitors
AU2014306778B2 (en) 2013-08-12 2020-10-29 Minerva Biotechnologies Corporation Method for enhancing tumor growth
CN103880841B (zh) * 2014-02-20 2016-04-13 南通大学 含有β-咔啉-3-酰亚肼基的HDAC抑制剂及其制备方法和用途
US11931347B2 (en) 2015-09-23 2024-03-19 Minerva Biotechnologies Corporation Method of screening for agents for differentiating stem cells

Similar Documents

Publication Publication Date Title
JP2019515643A5 (https=)
RU2448106C2 (ru) Новые гетероарил-замещенные бензотиазолы
JP2020521741A5 (https=)
JP2022505835A5 (https=)
JP6835472B2 (ja) 癌の処置のための組成物
RU2451018C2 (ru) Модуляторы атф-связывающих кассетных транспортеров
JP2017528498A5 (https=)
JP2010524939A5 (https=)
JP2020502103A5 (https=)
JP2009525353A5 (https=)
PE20050664A1 (es) Derivados de 1h-imidazo[4,5-c]quinolina
JP2004538251A5 (https=)
RU2007139634A (ru) Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения
MY209048A (en) Pyrrolotriazine derivatives for treating kit- and pdgfra-mediated diseases
CA2442256A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
JP2014513704A5 (https=)
JP2009536620A5 (https=)
JP2009528271A5 (https=)
JP2012513390A5 (https=)
JP2011518856A5 (https=)
JP2018515525A5 (https=)
JP2018514568A5 (https=)
JP2015520738A5 (https=)
CY1108061T1 (el) Παραγωγα κιναζολινης ως src αναστολεις κινασης τυροσινης
JP2017501983A5 (https=)